000			01954 a2200553 4500
005			20250513214659.0
264		0	_c20000810
008			200008s 0 0 eng d
022			_a0887-6924
024	7		_a10.1038/sj.leu.2401814 _2doi
040			_aNLM _beng _cNLM
100	1		_aHosler, G A
245	0	0	_aKinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia. _h[electronic resource]
260			_bLeukemia _cJul 2000
300			_a1215-24 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCalibration
650	0	4	_aCell Cycle
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aCytarabine _xtherapeutic use
650	0	4	_aDNA, Neoplasm _xgenetics
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Evaluation
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aLeukemia-Lymphoma, Adult T-Cell _xdrug therapy
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasm, Residual
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPrognosis
650	0	4	_aReference Standards
650	0	4	_aRisk Assessment
650	0	4	_aSpecific Pathogen-Free Organisms
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation, Heterologous
650	0	4	_aTumor Cells, Cultured _xtransplantation
650	0	4	_aVincristine _xtherapeutic use
700	1		_aBash, R
700	1		_aScheuermann, R H
773	0		_tLeukemia _gvol. 14 _gno. 7 _gp. 1215-24
856	4	0	_uhttps://doi.org/10.1038/sj.leu.2401814 _zAvailable from publisher's website
999			_c10864261 _d10864261